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Abstract
Understanding how avian influenza viruses adapt to human hosts is critical for the monitoring and prevention of future
pandemics. Host specificity is determined by multiple sites in different viral proteins, and mutation of only a limited number
of these sites can lead to inter-species transmission. Several of these sites have been identified in the viral polymerase, the
best characterised being position 627 in the PB2 subunit. Efficient viral replication at the relatively low temperature of the
human respiratory tract requires lysine 627 rather than the glutamic acid variant found systematically in avian viruses.
However, the molecular mechanism by which any of these host specific sites determine host range are unknown, although
adaptation to host factors is frequently evoked. We used ESPRIT, a library screening method, to identify a new PB2 domain
that contains a high density of putative host specific sites, including residue 627. The X-ray structure of this domain
(denoted the 627-domain) exhibits a novel fold with the side-chain of Lys627 solvent exposed. The structure of the K627E
mutated domain shows no structural differences but the charge reversal disrupts a striking basic patch on the domain
surface. Five other recently proposed host determining sites of PB2 are also located on the 627-domain surface. The
structure of the complete C-terminal region of PB2 comprising the 627-domain and the previously identified NLS-domain,
which binds the host nuclear import factor importin alpha, was also determined. The two domains are found to pack
together with a largely hydrophilic interface. These data enable a three-dimensional mapping of approximately half of PB2
sites implicated in cross-species transfer onto a single structural unit. Their surface location is consistent with roles in
interactions with other viral proteins or host factors. The identification and structural characterization of these well-defined
PB2 domains will help design experiments to elucidate the effects of mutations on polymerase–host factor interactions.
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Introduction
Influenza A viruses are orthomyxoviruses possessing an eight
segment RNA genome of negative polarity. Each segment is
packaged in a ribonucleoprotein complex (RNP) together with the
nucleoprotein (NP) and the three subunits (PA, PB1 and PB2) of
the trimeric RNA-dependent RNA polymerase, which mediates
viral transcription and replication in the host cell nucleus [1].
Influenza A viruses with sixteen different sub-types of haemag-
glutinin (HA) endemically infect wild waterfowl, and frequently
avian strains cause serious outbreaks of disease in domestic
poultry. Influenza A viruses have also adapted to infect mammals
and are a constant health risk for humans, causing seasonal
epidemics and, more rarely, serious pandemics. The latter can
arise when genome reassortments occur between avian and
human strains [2] or when avian strains mutate to become
infectious to and transmissible between humans, resulting in highly
pathogenic viruses to which the human population is not immune
[3]. This occurred notably in 1918 and led to an estimated 20–40
million deaths. Currently, highly pathogenic H5N1 avian strains
are of worldwide concern because with only a few mutations they
acquire the ability to infect humans with 60% mortality (http://
www.who.int/csr/disease/avian_influenza/country/en/), al-
though fortunately systematic human-to-human transmission of
such strains has not yet been reported. It is therefore of great
importance to understand the molecular mechanism of avian to
human host adaptation, as well as the factors leading to high
virulence, as this will contribute to effective monitoring of the
likelihood of a pandemic, the development of new diagnostic tools
and therapeutic strategies, and global counter-pandemic planning.
Studies have identified specific features of the receptor binding
glycoprotein, HA, the non-structural protein 1 (NS1) and the
polymerase as being critical for both inter-species transmission and
virulence [3]. Here we focus on the accumulating evidence that
the viral polymerase plays a major role in avian to human
transmission and that this is at least partly due to the requirement
of the polymerase to adapt to interacting host factors [4–9].
The PB2 residue at position 627, which in nearly all human and
avian influenza strains is either a lysine or glutamate respectively,
is the best characterised polymerase determinant of host range and
virulence. It was first identified using single gene reassortment
viruses showing that the avian glutamic acid variant had restricted
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viability [10]. Infection of mice with H5N1 influenza viruses from
a 1997 human outbreak in Hong Kong was either lethal or non-
lethal depending on the presence of Lys627 or Glu627,
respectively [11]. Whereas viral replication of these two strains
did not differ significantly in avian cell culture, growth in mouse
cells exhibited a strong preference towards Lys627 [12]. Despite
the clear importance of this residue for host specificity, little is
known about the functional mechanism. One hypothesis is that
residue 627 mediates interactions with essential host factors
involved in RNA transcription and replication that differ between
mammalian and avian species [13–15]. Although a number of
polymerase-interacting proteins have been proposed as potential
candidate host factors [9,16–18], none have been specifically
associated with the 627 position. A second hypothesis relates the
nature of the 627 residue with the temperature optimum of viral
replication. In humans, influenza viruses replicate in the upper
respiratory tract at about 33uC whereas in birds replication occurs
in the intestinal tract at 38–41uC. In an RNA replication assay
with reconstituted RNPs, Lys627-containing polymerase replicat-
ed more efficiently in mammalian cells at 33uC than polymerase
with Glu627, whereas at 37uC the difference was less marked [19].
Lys627 strains were subsequently shown to replicate more
efficiently than Glu627 strains in the cooler lung and nasal
turbinate tissues of mice, thus providing an environment for
positive selection of this mutation [20].
In addition to residue 627, PB2 residues 701 and 714 are also
implicated in host specific differences in polymerase efficiency, as
revealed by laboratory studies of the adaptation of pathogenic
avian strains to mice [5,21,22]. A study from our laboratory
provided the first structural insight into these host determinant
sites. We identified a C-terminal PB2 domain (residues 678–759)
bearing a bipartite nuclear localisation sequence (NLS) via
screening of a random library of expression constructs in E. coli
[23]. The solution NMR structure of this domain (denoted NLS-
domain) revealed the surface-exposed nature of Asp701 and
Ser714 as well as Arg702, a naturally occurring host specific
residue, which, with only rare exceptions, is an arginine in human
isolates and a lysine in avian strains [4,24,25]. The X-ray co-
crystal structure of the NLS-domain bound to the nuclear import
factor human importin a5 provided an atomic-level insight of PB2
interacting with a host factor. A direct contact observed between
Asp701 and the flexible NLS-containing C-terminus of PB2
suggested a role in modulating the PB2-importin interaction and
nuclear import efficiency. Subsequently it was shown that the
substitution D701N significantly affects the interaction of PB2 with
importin a1 in mammalian but not avian cells [9].
More generally, statistical analysis of multiple sequence
alignments based on large-scale influenza virus genome sequenc-
ing of avian and human isolates [26,27] allows identification of
candidate mutations that might contribute towards host specificity
[24,25,28]. An extensive analysis of thousands of avian and human
virus sequences identified 32 persistent host markers in 5 of the 11
viral proteins: PB2, PA, NP, M1 and NS1 [24]. Of these, 26
localize to the replication complex components PB2, PA and NP.
Another recent analysis identified 17 sites within the PB2 subunit
as putatively involved in avian to human adaptation [25]. These
results strongly support the notion that adaptation of the
replication complex to the host cell environment is a key event
in inter-species transmission.
Unfortunately, with the exception of the NLS-domain [23] and
most recently, the central cap-binding domain of PB2 [29], the
lack of atomic resolution structural information on the polymerase
precludes any detailed understanding of the functional role of
individual candidate residues. Here we extend the structure-based
exploration of host determinant residues through the identification
by random construct screening of a new PB2 domain (residues
538–693) that contains position 627 and is thus denoted the 627-
domain. The high resolution crystal structure of this domain from
a human influenza A strain and of the K627E variant, shows that
it has a novel fold with Lys/Glu627 exposed to the solvent. We
have also determined the structure of the complete C-terminal
region of PB2 (residues 538–759) which contains both the 627-
domain and the NLS-domain. These structures enable seven out
of a total 17 host specific sites on PB2 [25] to be mapped in three
dimensions. The majority are surface-exposed residues with the
potential to interact with either components of the polymerase
complex, or with host factors.
Results
Identification of 627-NLS-domain soluble protein
constructs
We identified two soluble protein constructs in the C-terminal
region of PB2 from strain A/Victoria/3/1975(H3N2), via
expression testing of random pb2 gene fragments using the
ESPRIT method [23,29]. Fragment sizes of 150–250 amino acids
were screened and several soluble constructs found that contained
the NLS-domain together with an N-terminal extension beginning
at residues 538 or 540. Minor proteolysis products observed
during purification of the longer construct (538–759) led to the
definition of two C-terminally truncated variants, comprising
residues 538–693 (lacking the NLS-domain) and 538–753 (with a
partly truncated NLS at the C-terminus of the NLS-domain). Both
constructs yielded crystals diffracting to high resolution (1.1 A ˚ and
1.9 A ˚ respectively) from which their structures were determined. A
notable feature of these protein fragments was the presence of
Author Summary
There is worldwide concern that currently circulating avian
influenza viruses will cross the species barrier and become
highly pathogenic, human transmissible strains with
pandemic potential. This could result from residue
changes in several influenza proteins, either by point
mutations, or through shuffling of the segmented avian
and mammalian viral genomes. Numerous studies have
highlighted potentially important residues for inter-species
transmission, and several are found in the influenza
polymerase that replicates and transcribes the viral
genome. The polymerase PB2 subunit contains a number
of such positions, notably residue 627, which is glutamic
acid in avian viruses but lysine in human-adapted strains.
Experiments have shown that the polymerase mutations
affect the efficiency of viral replication in different host
species, but the molecular mechanisms are unknown. As a
first step towards resolving this enigma, we have identified
a novel domain of PB2, containing many host determinant
sites, and determined its atomic structure by X-ray
crystallography. The species-specific residues are all
located on the domain surface, suggesting they could be
involved in interactions with viral proteins or host factors.
The 627 position is solvent-exposed in both the lysine and
glutamic acid variants, respectively either reinforcing or
disrupting a striking positively charged surface patch. The
identification and structural characterisation of biochem-
ically well-behaved domains of PB2 provides new tools for
understanding the phenomenon of inter-species transmis-
sion that is of global health importance.
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glutamate at this position, the K627E mutation was engineered
into the 538–693 construct, the corresponding protein crystallized
and its structure also determined.
Structure of the 627-domain and location of position 627
PB2 residues 538–676 form a compact, highly ordered domain
with a novel fold as indicated by the lack of structural homologues
found by DALI [30] (Figure 1). The N-terminal half (residues 538–
623) comprises a 6 helical cluster with a hydrophobic core rich in
aromatic residues. Some of these aromatic residues, notably in the
vicinity of Trp552 have previously been implicated in capped
RNA binding by cross-linking studies [31,32]. However the
structure gives no indication that they would form a ligand binding
site and furthermore it is now clear that the cap-binding site is
located elsewhere in PB2 [29], although it cannot be ruled out that
polymerase-bound mRNA also interacts with the 627-domain.
The C-terminal half of the 627-domain (residues 635–676)
comprises five short beta-strands which wrap around one side of
the helical bundle (Figure 1A). Linking the alpha- and beta- halves
of the domain is an extended peptide which wraps around helix a5
and contains the host-specific residue 627. This local region
contains most of the residues strictly conserved between influenzas
A, B and C (Figure 1C and Figure S4). The side-chain of Lys627 is
fully solvent exposed and indeed electron density beyond Cc is
lacking. In the crystal, the C-terminal extension of the domain
(residues 676–693) exhibits an extended conformation which is
determined by the crystal packing. The structure of the K627E
mutant domain is essentially identical (RMSD of 0.34 A ˚ for all Ca
atoms of residues 539–675), with the Glu627 side-chain (not visible
beyond Cc) again pointing into solvent. Thus the mutation
induces neither local nor global changes in the domain structure.
However, the charge reversal causes a major perturbation of the
electrostatic surface of the domain (Figure 2). A number of other
host determinant sites are also surface exposed on the 627-domain
(Figure 3). The domain fold is unlike any other known protein so
the structure in itself does not shed light on the functional role of
residue 627, although its exposed surface location suggests it might
mediate an interaction with another viral or host protein.
Structure of the double 627-NLS-domain
The 1.95 A ˚ resolution structure of the double 627-NLS-domain
(residues 539–753) shows that the two domains pack side by side
forming a single module (Figure 1B). The well-structured part of
each domain shows only minor differences from that observed in
either the isolated 627-domain (RMSD of 0.5 A ˚ for all Ca atoms
of residues 540–675) or the NLS-domain in complex with importin
a5 [23] (RMSD of 0.78 A ˚ for all Ca atoms of residues 694–738).
Only the inter-domain linker (residues 678–692) and the visible
part of the bipartite NLS (residues 736–741), both presumably
flexible, show different conformations (Figure S1 and Figure S2).
The inter-domain linker comprises two parts: residues 678–685
form a poorly ordered, flexible region while residues 686–692
form a well-ordered interface between the two domains. This
interface comprises 11 hydrogen bonds including one salt bridge
(Glu687 to Arg650) as well as burying hydrophobic residues on
helix a5 of the 627-domain and on the NLS-domain (Figure S3).
According to PISA (http://www.ebi.ac.uk/msd-srv/prot_int/
pistart.html), the interface buries respectively 820 and 925 A ˚ 2 of
solvent accessible surface of the 627- and NLS-domains. Given the
flexible nature of the linkage between the two domains, it remains
to be seen whether this moderately strong interface is of biological
significance. The complete 627-NLS double domain (residues
538–759) was observed to form a stable complex in vitro with
human importin a1 by size exclusion chromatography (Figure S5)
as shown for the NLS-domain alone with human importin a5 [23].
A functional PB2-importin a1 interaction has previously been
demonstrated by cellular studies [9].
Discussion
The influenza polymerase has long resisted atomic resolution
structural studies due to the problem of obtaining large amounts of
material in soluble form. An important aspect of this is the inability
to predict bioinformatically the domain structure of the polymer-
ase subunits due to their unique sequences, apart from the
polymerase domain of PB1. Previously we have used ESPRIT, a
new method for screening for soluble protein fragments from
random gene truncation libraries, to identify two functional
domains from PB2; the C-terminal NLS-domain involved in
nuclear import [23] and the cap-binding domain that participates
in the ‘cap-snatching’ mode of transcription of viral mRNAs by
binding the m
7GTP 59 extremity of host pre-mRNAs [29]. This
domain-based approach has allowed us to derive the first high
resolution structural information about this previously recalcitrant
complex, although an understanding of how these domains
function in the active trimeric complex clearly awaits a structure
determination of the complete polymerase. Here, we have
identified a third E. coli expressible domain from PB2 (538–693),
termed the 627-domain after the most well-characterised host
determinant site contained within it at position 627. The 156
amino acid 627-domain is located between the cap-binding and
NLS-domains and contains six of the seventeen host species
determining sites described within the PB2 subunit: N567D/E,
I588A/V, T613V/A, K627E, T661A, T674A/S (Figure S4)
where for each position the consensus human and then avian
residues are given [25]. Thus the definition of this new domain
locates a high density of host determinant sites onto a single
structural unit (Figure 3). By contrast the similar sized PB2 cap-
binding domain (residues 318–483)[29] has only two host
determinant sites (K368R and M475L) [25]. The complete C-
terminal region, comprising both the 627-domain and NLS-
domain, also includes the host variable residue R702K and, in the
inter-domain linker, the HxN2 subtype host determinants S682G
and S684A [25].
The atomic structures reveal that all seven of the host-
determining residues are located on the surface of the double
domain (Figure 3). In addition, the residues 701 and 714, whose
mutation (respectively D701N and S714R) have been shown to
affect polymerase activity in a laboratory model of adaptation of
virulent strains from birds to mice [5,22], are located on the
surface of the NLS-domain. The Lys627 side-chain is solvent
exposed and forms part of a striking, positively-charged surface
patch which also includes residues Lys586, Arg589, Arg597 and
Arg630 (Figure 2A). This basic region is severely disrupted by the
charge reversal upon mutation to glutamic acid (Figure 2B). In
crystal structures of both the Lys and Glu variants of the 627-
domain, superposition reveals no structural rearrangement of the
domain upon mutation and in each case the side-chain is solvent
exposed and partially disordered, most likely due to multiple
conformations. The temperature effects on viral replication
observed previously cannot therefore be explained in simple terms
of structural differences between the Glu and Lys variants, at least
at the domain level. Although, the role of the 627 amino acid
remains enigmatic, the occurrence of a high density of host
determinant residues on the surface of the C-terminal double
domain of PB2 is suggestive that this region interacts with host
factors, particularly in contrast to the PB2 cap-binding domain,
Influenza A Polymerase PB2 Subunit 627-Domain
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markedly low density of host determinant residues [25]. It is also
possible that variant residues do not make direct protein contacts
but, by affecting protein flexibility, help other regions to maintain
polymerase activity or promote interactions with other domains or
host factors.
From an analysis of H5N1 viruses isolated from infected humans
in Vietnam it was observed that in 5/8 fatal and 3/4 non-fatal cases
the E627K mutation had occurred [7]. Interestingly, in 3/4 cases
retaining Glu627, but none of those with E627K, the D701N
mutation was also found, leading to the suggestion that the latter
mutation may compensate for the lack of change at position 627.
Since we have hypothesised that position 701 may be involved in
modulating the interaction with the nuclear import factor importin
a [9,23], we were prompted into investigating whether position 627
could also interact with the same host factor. Mixing purified 627-
NLS-domain and importin a1 resulted in a stable complex as
observed by size exclusion chromatography (Figure S5). A
superposition of the double 627-NLS-domain structure, assuming
Figure 1. Structure and sequence alignment of C-terminal domains of influenza polymerase PB2 subunit. (A) Ribbon diagram of the
627-domain showing secondary structure elements and the position of human specific lysine 627. Helices are in red and beta-strands in yellow as
defined by DSSP [30]. The conformation of the C-terminal tail (residues 676–693) is determined by crystal contacts. The structure shown is of the
SeMet labelled protein. (B) Ribbon diagram of the 627-NLS-double domain showing the position of lysine 627. The 627-domain is in red and yellow,
the core NLS-domain in cyan and blue and the truncated nuclear localization peptide in purple. The flexible inter-domain linker is in green. Figure 1A
and Figure 1B were drawn with MOLSCRIPT [42] and rendered with RASTER3D [43]. (C) Sequence alignment of C-terminal regions of PB2 from
influenza A and B viruses with superimposed secondary structure. The coloured bar under the alignment indicates the 627-domain (red), linker
(green), core NLS-domain (cyan) and the bipartite NLS (purple). The seven host specific residues identified in this region [25] are indicated with a blue
square in the coloured bar. Alignment figure produced with ESPript [44].
doi:10.1371/journal.ppat.1000136.g001
Figure 2. Effect of the K627E mutation on the electrostatic
surface of the 627-domain. The electrostatic surface potentials were
calculated from the crystal structures of (A) the Lys627 human
determinant-containing domain, and (B) the Glu627 avian-like variant
using DelPhi [45] and displayed using PyMol [46]. The potential scale
ranges from -4 kT/e (red) to 4 kT/e (blue). The maps reveal that the
K627E substitution disrupts a prominent basic surface patch which also
includes residues Lys586, Arg589, Arg597, Arg630 and Arg646.
doi:10.1371/journal.ppat.1000136.g002
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a5 via the common NLS-domain shows that there would be a
significant clash of the 627-domain with the C-terminal region of
importin a. Thus binding to importin a of the full-length PB2
(which includes the double domain), rather than just the extreme C-
terminal NLS-domain, would require some flexibility at the level of
the link between the bipartite NLS peptide and the core of the NLS-
domain, if the double domain remains a rigid unit as observed
crystallographically. Alternatively PB2 binding to importin a might
only be possible if the 627- and NLS-domains were juxtaposed
differently than observed in the crystal. Both possibilities are
plausible, especially given the nature of the flexible linker between
the domains and the fact that each domain is independently folded
and soluble. Thus both the structure of the double domain in the
context of the separate full-length PB2 subunit or the trimeric
polymerase and the possible interaction of the 627-domain with
importin a (or any other host factor) remain open questions.
It is reasonable to hypothesise that mutations of host
determining sites in the influenza polymerase are required to
adapt interactions with host specific factors. A number of putative
host factors for the polymerase have been identified by two-hybrid
[33,34], proteomic [16,18] and other methods [17], but with the
exception of Asp701 and its possible influence on importin binding
[9,23], the effects of mutations upon interactions with these
putative partners have not been investigated. The structurally
compact and biochemically well-behaved PB2 domains charac-
terised here and previously [23,29] will facilitate improved screens
using well-defined bait proteins and should result in more specific
interactions being identified. The effects of mutations upon
protein-protein affinities of these domain-host factor complexes
can then be measured and structural studies will help in
understanding the nature of the interaction interfaces and the
contributions of the surface-exposed host determinant residues.
Materials and Methods
Identification of C-terminal expression constructs
The pb2 gene from A/Victoria/3/1975(H3N2) was codon-
optimised for expression in E. coli (Geneart) and cloned into a
modified pET9a vector (Novagen) with N-terminal hexahistidine
tag and TEV protease cleavage sequence (MGHHHHHHDY-
DIPTTENLYFQG) and C-terminal biotin acceptor peptide with
Figure 3. Identification of host species determinant sites. Surface representations highlight the position of the sites on the (A) 627-domain
and (B) 627-NLS-domain in two different orientations. In (B) the 627-domain and NLS domain are respectively in grey and dark grey. Major host
specificity determinant residues [25] are shown in green and with those for HxN2 subtype in blue. Residues 714 and 701 (yellow) were identified as
host specificity determinants in a laboratory model of avian to mouse transmission [5].
doi:10.1371/journal.ppat.1000136.g003
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59 AatII/AscI and 39 NsiI/NotI sites flanked the pb2 gene enabling
generation of internal gene fragments by sequential exonuclease
III truncation reactions [23,35] to generate a library of inserts
fused to both tags after blunt-end generation and ligation [29].
Plasmids with 450-750 nucleotide pb2 inserts were excised from
1% agarose gel prior to the second ligation step, then recovered by
transforming Mach1 cells (Invitrogen). Purified DNA was
prepared from about 35,000 pooled colonies and electroporated
into E. coli strain BL21 AI (Invitrogen) containing the RIL plasmid
(Stratagene). Colony blots of approximately 27,000 clones were
hybridized with Alexa 488 streptavidin (Invitrogen) and screened
for expression constructs by fluorimager [23]. Two clones
expressing purifiable C-terminal PB2 proteins (amino acids 538–
759 and 540–759) were identified within the first 96 most
fluorescent clones. The 538–759 protein cleaved better with
TEV protease, but exhibited some C-terminal proteolytic
degradation at 4uC during storage. Mass spectrometry identifica-
tion of these products revealed two stable fragments (538–693 and
538–753) that were sub-cloned in to the same modified pET9a
vector as described above. The mutation K627E in the 538–693
protein was made by PCR mutagenesis.
Protein purification and labelling
Native proteins were expressed in E. coli strain BL21 AI RIL in
TB medium. Partially selenomethionine labelled 538–693 protein
was produced using M9 medium supplemented with 50 mg/l of
selenomethionine and 5 mg/l of methionine. Protein expression
was induced by the addition of 0.2% w/v arabinose for 20 h at
25uC. Cells were resuspended and sonicated in lysis buffer (30 mM
Tris-HCl pH 7.0, 200 mM NaCl). Proteins were purified on Ni
2+
chelating sepharose column (GE Healthcare). Columns were
intensively washed with 4 different buffers (30 mM Tris-HCl
pH 7.0, 200 mM NaCl; 10 mM Tris-HCl pH 7.0, 1 M NaCl;
10 mM Tris-HCl pH 7.0, 200 mM NaCl, 50 mM imidazole;
10 mM Tris-HCl pH 7.0, 200 mM NaCl, 75 mM imidazole) and
the proteins were eluted with elution buffer (10 mM Tris-HCl
pH 7.0, 200 mM NaCl, 500 mM imidazole). The hexahistidine
tag was removed with TEV protease overnight at 15uC leaving an
additional N-terminal glycine residue. Proteins were dialyzed
against 10 mM Tris-HCl pH 7.0, 200 mM NaCl and a second
Ni
2+ chelating sepharose column was used to remove unwanted
material. Proteins were then purified by gel filtration on Superdex
75 column (GE Healthcare).
Interaction assay between large C-terminal PB2 domain
and human importin a1 by size exclusion
chromatography
Hexahistidine-tagged human importin a1 (KPNA2; residues 60–
529) and the 627-NLS-domain (with two additional C-terminal
alanine residues from cloning) were purified and the affinity tags
removed by TEV digestion. They were then mixed at a 1:2 molar
ratio (importin:PB2) overnight at 4uC. Proteins were concentrated to
5.5 mg/ml and purified using a Superdex S200 size exclusion
column (GE Healthcare) in 10 mM Tris-HCl pH 7.0, 200 mM
NaCl.
Crystallization
Hanging drop vapour diffusion trials were performed at 20uC.
Native, mutated and partially selenomethionine labelled 538–693
PB2 protein crystals were grown by mixing 1 ml of 2.4 mg/ml
protein solution in 10 mM Tris-HCl pH 7.0 and 200 mM NaCl
with 1 ml of 100 mM citric acid pH 4.0–7.0 and 1.4–1.6 M
ammonium sulfate solution. Native 538–753 PB2 protein crystals
were grown by mixing 1 ml of 5.5 mg/ml protein solution in
10 mM Tris-HCl pH 7.0 and 200 mM NaCl with equal volume
of 100 mM Hepes pH 7.5 and K/Na Tartrate 1.2 M. Crystals
were frozen in liquid nitrogen after soaking in crystallization
solution supplemented with 30% glycerol.
Crystallography
Crystals of the 627-domain (residues 538–693) with Lys627
(native and selenomethionine labelled), the 627-domain with
Glu627 (native) and the 627-NLS-domain (native, residues 538–
753) were measured at the European Synchrotron Radiation
Facility (ESRF). Table 1 gives all data collection and refinement
statistics. All crystals have one molecule in the asymmetric unit. All
data were integrated with XDS [36] and analysed using the CCP4i
package [37]. The structure of the 627-domain with Lys627 was
solved by the SAD method using AUTOSHARP [38] which found
5 selenium positions. ARP/wARP [39] was used for automatic
model building. The structure of the K627E mutant was obtained
by refinement. The double domain structure was solved by
molecular replacement using PHASER [40] and, as search models,
the 627-domain and the NLS-domain from the complex with
human importin a5 (PDB id: 2JDQ). All refinements were
performed with REFMAC [41] with added hydrogen atoms. For
the very high resolution native 627-domain and K627E structures
individual atomic anisotropic B-factors were refined. In the 627-
domain alone structures, the 640–644 loop is disordered and the
609–610 loop has multiple conformations; both regions are well
ordered in the 627-NLS-domain structure. The linker region 678–
685 is poorly ordered in the 627-NLS-domain structure, but
residual discontinuous density unambiguously defines which 627-
domain is connected to which NLS-domain in the crystallographic
asymmetric unit. Diffraction data for the 627-domain alone extend
to very high resolution (1.1 A ˚ for the native Lys627 data).
Paradoxically the highest resolution data does not yield the most
complete model; for example in the Lys627 native structure there is
no electron density for the extended C-terminal tail of the 627-
domain (residues 676–693), whereas this is perfectly ordered in the
SeMet data and mostly ordered intheGlu627 data.Inthelatter two
structures many multiple conformations can be modelled (Table 1).
According to MOLPROBITY all structures have excellent
geometry (http://molprobity.biochem.duke.edu/).
Database deposition
The co-ordinates and structure factors of the PB2 domains are
available from the PDB with codes 2vy6 for the 627-NLS double
domain (native data), 2vy7 for the 627-domain with Lys627
(selenomethionine labelled protein) and 2vy8 for the 627-domain
with Glu627 (native data).
Supporting Information
Figure S1 Comparison of the structure of the isolated 627-
domain (pink) with that in the double 627-NLS-domain (red). The
domain is in the same orientation as that of Figure 1B. Helices are
marked according to the secondary structure assignment.
Significant differences are observed only in the conformation of
the flexible region 676-693.
Found at: doi:10.1371/journal.ppat.1000136.s001 (4.30 MB TIF)
Figure S2 Comparison of the structures of the NLS-domain.
The NLS-domain (blue) from the double 627-NLS-domain has
been superimposed on that in the complex with human importin
a5 (PDB: 2JDQ; light blue). Visible secondary structural elements
are labelled as in the double 627-NLS-domain. Significant
Influenza A Polymerase PB2 Subunit 627-Domain
PLoS Pathogens | www.plospathogens.org 6 August 2008 | Volume 4 | Issue 8 | e1000136differences are observed at the two extremities of the domain. In
particular residues 686-692 are helical in the importin complex
but extended in the double domain.
Found at: doi:10.1371/journal.ppat.1000136.s002 (2.34 MB TIF)
Figure S3 Diagram showing hydrogen bonds at the interface
between the 627- (red) and NLS- (cyan) domains in the 627-NLS-
domain structure. The interface comprises 11 hydrogen bonds
(dotted green with distances between acceptor and donor marked)
including one salt bridge (Arg650 to Glu687). Several hydrophobic
residues on helix a5 of the 627-domain (e.g. Phe595, Leu599,
Met603, Val606) and from the NLS-domain (e.g. Ile710 and
Ile726) are buried or partially buried at the interface. For clarity,
these residues are not shown.
Found at: doi:10.1371/journal.ppat.1000136.s003 (2.94 MB TIF)
Figure S4 Sequence alignment of the 627-domain from human
(H3N2) and avian (H5N1) strains of influenza A, influenza B and
influenza C with superposed secondary structure. Residues with a
red background are conserved in all strains; these are primariliy in
the helices a5 and a6 in proximity to the residue 627, which is a
lysine in all strains except avian. The purple boxes indicate
differences between the human and avian influenza A strains. All
the differences highlighted by Miotto et al. [25] occur as well as
some non-consensus changes (G590C and I676T).
Found at: doi:10.1371/journal.ppat.1000136.s004 (0.52 MB TIF)
Figure S5 Interaction assay between large C-terminal PB2
domain and human importin a1 by size exclusion chromatogra-
phy. Fractions were analyzed by SDS-PAGE revealing a major
peak comprising a complex of importin a1 and 627-NLS-domain
(fractions 25 to 29) and a minor peak containing excess unbound
627-NLS-domain (fractions 31 to 36). The 627-NLS domain alone
eluted in fractions 31 to 36 (not shown).
Found at: doi:10.1371/journal.ppat.1000136.s005 (3.81 MB TIF)
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Beamline (ESRF) BM14 BM14 ID23-2 ID23-1
Wavelength (A ˚) 1.008 0.979 0.873 0.954
Space group C2 C2 C2 P21
Cell dimensions
a, b, c (A ˚) 48.3, 45.5, 59.9 48.4, 45.0, 60.0 48.5, 45.7, 60.8 33.4, 65.4, 45.5
a, b, c (u) 90.0, 105.4, 90.0 90.0, 105.5, 90.0 90.0, 106.2, 90.0 90.0, 92.0, 90.0
Resolution (A ˚) 50-1.10 (1.10–1.16)* 58–1.53 (1.53–1.58)* 30–1.15 (1.15–1.20)* 30–1.95 (1.95–2.00)*
Rmerge 0.031 (0.393) 0.042 (0.170) 0.098 (0.327) 0.128 (0.572)
I/sI 16.8 (3.1) 20.2 (5.3) 5.07 (2.50) 8.95 (2.28)
Completeness (%) 94.4 (87.6) 97.6 (77.3) 92.9 (85.9) 98.3 (92.9)
Redundancy 3.66 (2.72) 3.67 (2.28) 2.84 (1.39) 4.01 (3.09)
Refinement
Resolution (A ˚) 30–1.1 (1.10–1.13)* 58–1.53 (1.53–1.57)* 30–1.20 (1.20–1.23)* 30–1.95 (1.95–2.00)*
Total No. reflections/free 45464/2439 17685/960 35705/1874 13456/712
Rwork 0.181 (0.239) 0.144 (0.159) 0.189 (0.254) 0.200 (0.265)
Rfree 0.192 (0.266) 0.185 (0.251) 0.214 (0.281) 0.258 (0.390)
No. atoms 1212 1535 1404 1649
Protein 1083 1361 1279 1572
Water 129 174 125 77
No. residues modelled with multiple
conformations
-2 2 1 9 -
Average B-factors (A ˚2) 12.65 7.51 9.91 21.4
R.m.s. deviations
Bond lengths (A ˚) 0.008 0.015 0.014 0.015
Bond angles (u) 1.26 1.57 1.54 1.61
Ramachandran Plot**
Favoured (%) 100 97.9 100 98
Allowed (%) 100 100 100 100
*Values in parentheses are for highest-resolution shell.
**Molprobity: http://molprobity.biochem.duke.edu/
doi:10.1371/journal.ppat.1000136.t001
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